Trial · NCT04581863
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in Days Alive and Out of Hospital | 30 days | Primary outcome will be reported for patients who are confirmed to be COVID positive. Outcomes include time-based and categorical clinical outcomes. Time-based measures will be assessed at 30 days and begin when a COVID-19 patient was tested (e.g., nasopharyngeal swab) in outpatient and ED settings, or starting at the time of discharge from the hospital if enrolled in COVID Watch as an inpatient. Staying safe and out of the hospital using Days Alive and Out of Hospital (DAOH) since the date of the positive COVID-19 test. Initial analyses will include in-hospital deaths. Deaths that occur outside the hospital in 2020 will be added to a follow up analysis when National Death Index (NDI) becomes available (est. January 2021)." |
| Other | Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The mean number of days is per person. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Self-reported Anxiety Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate their anxiety (1=very worried to 5=not at all worried) on Day 0, 7, and 14. |
| Other | Self-perception of Confidence in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate their confidence that they could manage their symptoms at home (1=not at all confident to 5=very confident) on Day 0, 7, and 14. |
| Other | Self-perception of Program Helpfulness in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate how helpful these found the program (1=not at all helpful to 5=very helpful) on Day 0, 7, and 14. |
| Other | Mortality Among COVID-19 Positive Patients | 30 days | The count of participants encompasses all deaths in each arm. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Mortality by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The count of participants encompasses all deaths with respect to each arm and each race/ethnic group. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) | 30 days | The mean number of visits/hospitalizations is per patient. Emergency and Hospitalizations include patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. Office visits are within the Penn health system and do not include patients who presented to any of 53 hospitals outside the Penn health system captured in the regional health information exchange. |
| Other | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The mean number of visits/hospitalizations is per patient. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. Office visits are within the Penn health system and do not include patients who presented to any of 53 hospitals outside the Penn health system captured in the regional health information exchange. |
| Other | Incidence of Remote Monitoring Escalations to Clinician | 30 days | Escalations to a clinician represents the number of unique patients who escalated to a clinician one or more times throughout enrollment per their allocated study. |
| Other | Timing of Remote Monitoring Escalations to Clinician | 30 days | Mean represents average clinician response time in minutes to escalations. |
| Other | Self-Reported Symptom Self-Management Among COVID-19 Positive Patients | 30 days | Patients were asked after an escalation to a clinician how they would have self-managed their COVID symptoms if not for the COVID Watch program (A. Gone to ER, B. Contacted my doctor, C. Stayed at home, or D. Other). |
| Other | Days Between Program Enrollment and Home Pulse Oximetry Initiation | 30 days | SpO2 denotes peripheral capillary oxygen saturation. This is the number of days between when patients were enrolled to when they initiated the pulse oximetry. This only applies to the COVID Watch + Pulse Oximeter patients. |
| Other | Timing of Initial Presentation of Covid-19 Positive Patients Who Returned to Emergency Department | 30 days | Days from enrollment to ED return visit includes patients who presented to any of 53 hospitals outside the health system captured in the regional health information exchange. ED denotes Emergency Department. Days from enrollment to ED return visit in Penn Health System does not include patients who presented to any of 53 hospitals outside the health system captured in the regional health information exchange. ED denotes Emergency Department. |
| Other | Severity of Initial Presentation of Covid-19 Positive Patients Who Returned to Emergency Department as Measured by Oxygen Saturation | 30 days | Lowest recorded oxygen saturation percentage does not include patients who presented to any of 53 hospitals outside the health system captured in the regional health information exchange. ED denotes Emergency Department. |
| Other | Incidence of Subsequent Emergency Department Referrals | 30 days | Total escalations represent number of total escalations, including multiple from same patient. Clinical recommendations, including referrals, followed an pre-specified clinical protocol |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04581863/registered